12:00 AM
 | 
Dec 03, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Raxone idebenone regulatory update

Santhera pushed back the expected timeline to early 2013 from year end for an opinion from EMA's CHMP for an MAA for Raxone...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >